Core Scientific, Inc. (NASDAQ:CORZ) Shares Sold by Boothbay Fund Management LLC

Boothbay Fund Management LLC reduced its position in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 25.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 612,065 shares of the company’s stock after selling 207,468 shares during the period. Boothbay Fund Management LLC owned 0.22% of Core Scientific worth $8,600,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC increased its position in shares of Core Scientific by 25.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock worth $1,378,000 after purchasing an additional 20,000 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock valued at $5,192,000 after buying an additional 142,068 shares during the last quarter. FNY Investment Advisers LLC lifted its stake in shares of Core Scientific by 35.8% in the fourth quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company’s stock worth $2,679,000 after buying an additional 50,275 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in Core Scientific during the fourth quarter worth about $527,000. Finally, Stephens Inc. AR purchased a new stake in Core Scientific during the 4th quarter valued at about $927,000.

Insider Buying and Selling at Core Scientific

In related news, Director Jordan Levy purchased 62,500 shares of the business’s stock in a transaction on Thursday, March 6th. The shares were bought at an average price of $8.01 per share, for a total transaction of $500,625.00. Following the acquisition, the director now directly owns 306,887 shares in the company, valued at $2,458,164.87. This trade represents a 25.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the completion of the transaction, the director now owns 195,687 shares of the company’s stock, valued at $2,103,635.25. The trade was a 40.69 % decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

Core Scientific Trading Up 10.4 %

Shares of NASDAQ CORZ opened at $8.31 on Friday. The stock has a fifty day simple moving average of $8.29 and a 200-day simple moving average of $12.37. Core Scientific, Inc. has a twelve month low of $2.88 and a twelve month high of $18.63. The stock has a market capitalization of $2.45 billion, a PE ratio of -1.54 and a beta of 6.80.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.09. The business had revenue of $94.93 million for the quarter, compared to analyst estimates of $97.07 million. On average, equities analysts predict that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CORZ. Compass Point lowered their target price on Core Scientific from $26.00 to $20.00 and set a “buy” rating on the stock in a report on Tuesday, February 25th. Needham & Company LLC reduced their price target on Core Scientific from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, February 27th. Craig Hallum assumed coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They set a “buy” rating and a $24.00 price target on the stock. Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a research report on Monday, January 27th. They set an “outperform” rating and a $22.00 price objective for the company. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 target price on shares of Core Scientific in a report on Wednesday, March 12th. Fifteen equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Core Scientific has an average rating of “Buy” and an average target price of $19.07.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.